ZhaoYuan (Tony) Chen is the founder of Phrontline Biopharma. Phrontline Biopharma has raised $68M in total funding. Latest round: Pre-A+.
ZhaoYuan (Tony) Chen is the founder of Phrontline Biopharma, a clinical-stage biotechnology company focused on advancing bispecific and dual-payload antibody-drug conjugates (ADCs). He has led the company through significant funding rounds, including a Pre-A round of over 100 million RMB and a Pre-A+ round of $60 million.
Full founder directory · Investor directory · Company funding database · Fundraising library